Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-10-05
2000-08-15
Higel, Floyd D.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
514277, 514357, 514562, 514567, 544283, 544301, 546162, 548198, 548215, 5483361, 5483701, 548571, 549 74, 549491, 562426, 562440, C07D21170, C07D21182, A61K 31435, A61K 31195, C07C32100, C07C24900
Patent
active
061039071
ABSTRACT:
Phenylalkylcarboxylic acid compounds of the formula: ##STR1## wherein R.sup.1 represents an alkyl group and the like, R.sup.2 represents an alkylene group, R.sup.3 represents a hydrogen atom and the like, X represents a substituted or unsubstituted aryl group and the like, Y represents an oxygen atom and the like, Z represents an alkylene group and the like, and W represents an alkyl group and the like),
the pharmacologically acceptable salts thereof or the pharmacologically acceptable esters thereof are useful as therapeutic or preventive agents for hyperglycemia and the like.
REFERENCES:
patent: 3872113 (1975-03-01), Fliedner
patent: 4703052 (1987-10-01), Eggler et al.
patent: 5530156 (1996-06-01), Benori et al.
patent: 5863946 (1999-01-01), Brooks et al.
Fujita et al, "Reduction of Insulin Resistance in Obese and/or Diabetic Animals by 5-[4-(1-Methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone, a New Antidiabetic Agent", Diabetes, vol. 32 (9), pp. 804-810 (Sep. 1983).
Fujiwara et al, "Characterization of New Oral Antidiabetic Agent CS-045", Diabetes, vol. 37 (11), pp. 1549-1558 (Nov. 1988).
Chang et al, "The Hypoglycemic Effect of Ciglitazone in Obese, Hyperglycemic Animal Models", Prog. Clin. Biol. Res., 265, pp. 177-192 (1988).
Colca et al, "Ciglitazone, A Hypoglycemic Agents: Early Effects on the Pancreatic Islets of Ob/Ob Mice", Metabolism, vol. 37, No. 3, pp. 276-280 (Mar. 1988).
Sohda et al, "Studies on Antidiabetic Agents", Arzneim-Forsch., vol. 40 (1), pp. 37-42 (1990).
Ikeda et al, "Effects of Pioglitazone on Glucose and Lipid Metabolism in Normal and Insulin Resistant Animals", Arzneim-Forsch., vol. 40 (2), pp. 156-162 (1990)
Sugiyama et al, "Effects of Pioglitazone on Glucose and Lipid Metabolism in Wistar Fatty Rats", Arzneim-Forsch, vol. 40 (3), pp. 263-267 (1990).
Colca et al, "Pioglitazone Hydrochloride Inhibits Cholesterol Absorption and Lowers Plasma Cholesterol Concentrations in Cholesterol-Fed Rats", Diabetes, vol. 40 (12), pp. 1669-1674 (Dec. 1991).
Saha et al, "Lipid abnormalities in tissues of the KKA.sup.y mouse: effects of pioglitazone on malonyl-CoA and diacylgylcerol", Am. J. Physiol., 267 (1, Pt. 1), pp. E95-E101 (1994).
Oakes et al, "A New Antidiabetic Agent, BRL 49653, Reduces Lipid Availability and Improves Insulin Action and Glucoregulation in the Rat", Diabetes, vol. 43 (10), pp. 1203-1210 (Oct. 1994).
Bowen et al, "The Effect of CP 68,772, a Thiozolidinedione Derivative, on Insulin Sensitivity in Lean and Obese Zucker Rats", Metabolism, vol. 40 (10), pp. 1025-1030 (Oct. 1991).
Kemnitz et al, "Pioglitazone Increases Insulin Sensitivity, Reduces Blood Glucose, Insulin, and Lipid Levels, and Lowers Blood Pressure in Obese, Insulin-Resistant Rhesus Monkeys", Diabetes, vol. 43 (2), pp. 204-211 (Feb. 1994).
Keen, "Insulin Resistance and the Prevention of Diabetes Mellitus", The New Eng. Journal of Med., vol. 331 (18), pp. 1226-1227 (Nov. 1994).
Yoshioka et al, "Antihypertensive Effects of CS-045 Treatment in Obese Zucker Rats", Metabolism, vol. 42, No. 1, pp. 75-80 (Jan. 1993).
Dubey et al, "Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats", Am. J. Physiol., vol. 265 (4, Pt. 2), pp. R726-R732 (1993).
Ohsumi et al, "Troglitazone Prevents the Inhibitory Effects of Inflammatory Cytokines on Insulin-Induced Adipocyte Differentiation in 3T3-L1 Cells", Endocrinology, vol. 135. No. 5, pp. 2279-2282 (1994).
Szalkowski et al, "Antidiabetic Thiazolidinediones Block the Inhibitory Effect of Tumor Necrosis Factor-.alpha. on Differentiation, Insulin-Stimulated Glucose Uptake, and Gene Expression in 3T3-L1 Cells", Endocrinology, vol. 136, No. 4, pp. 1474-1481 (1995).
Shikazumi et al, "Efficacy of Pioglitazone on Renal Glomerular Lesions in Wistar Fatty Rats", Diabetes, vol. 38 (Special Edition) (38th Annual Technical Meeting of the Japan Diabetes Society, Program Proceedings, 38th Meeting of the Japan Diabetes Society), Program No. 2695 (with an English language translation) (1995).
Fujita Takashi
Fujiwara Toshihiko
Takamura Makoto
Yanagisawa Hiroaki
Higel Floyd D.
Sankyo Company Limited
LandOfFree
Phenylalkylcarboxylic acid compounds and compositions for treati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenylalkylcarboxylic acid compounds and compositions for treati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylalkylcarboxylic acid compounds and compositions for treati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2008534